Systematically Prioritizing Functional Differentially Methylated Regions (fDMRs) by Integrating Multi-omics Data in Colorectal Cancer

While genome-wide differential DNA methylation regions (DMRs) have been extensively identified, the comprehensive prioritization of their functional importance is still poorly explored. Here, we aggregated multiple data resources rooted in the genome, epigenome and transcriptome to systematically prioritize functional DMRs (fDMRs) in colorectal cancer (CRC). As demonstrated, the top-ranked fDMRs from all of the data resources showed a strong enrichment for known methylated genes. Additionally, we analyzed those top 5% DMR-coupled coding genes using functional enrichment, which resulted in significant disease-related biological functions in contrast to the tail 5% genes. To further confirm the functional importance of the top-ranked fDMRs, we applied chromatin modification alterations of CRC cell lines to characterize their functional regulation. Specifically, we extended the utility of the top-ranked DMR-coupled genes to serve as classification and survival biomarkers, which showed a robust performance across diverse independent data sets. Collectively, our results established an integrative framework to prioritize fDMRs, which could help characterize aberrant DNA methylation-induced potential mechanisms underlying tumorigenesis and uncover epigenome-based biomarkers for clinical diagnosis and prognosis.

[1]  Andrew P. Stubbs,et al.  Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. , 2011, Cancer cell.

[2]  Caleb Webber,et al.  GAT: a simulation framework for testing the association of genomic intervals , 2013, Bioinform..

[3]  Jingde Zhu,et al.  Whole-genome DNA methylation profiling using MethylCap-seq. , 2010, Methods.

[4]  Yitzhak Pilpel,et al.  Differentially Regulated Micro-RNAs and Actively Translated Messenger RNA Transcripts by Tumor Suppressor p53 in Colon Cancer , 2006, Clinical Cancer Research.

[5]  Daisuke Hattori,et al.  DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation , 2003, Science.

[6]  Michael B. Stadler,et al.  Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome , 2007, Nature Genetics.

[7]  G. Turecki,et al.  Functional DNA methylation in a transcript specific 3′UTR region of TrkB associates with suicide , 2014, Epigenetics.

[8]  J. Issa.  CpG island methylator phenotype in cancer , 2004, Nature Reviews Cancer.

[9]  Madeleine P. Ball,et al.  Corrigendum: Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells , 2009, Nature Biotechnology.

[10]  A. West,et al.  Insulators and boundaries: versatile regulatory elements in the eukaryotic genome. , 2001, Science.

[11]  Xia Li,et al.  Prioritizing cancer-related key miRNA–target interactions by integrative genomics , 2012, Nucleic acids research.

[12]  H. Ikeuchi,et al.  Gene expression of mesenchyme forkhead 1 (FOXC2) significantly correlates with the degree of lymph node metastasis in colorectal cancer. , 2011, International surgery.

[13]  Taylor Jensen,et al.  Epigenetic inactivation of the HOXA gene cluster in breast cancer. , 2006, Cancer research.

[14]  I. Maillard,et al.  From the cradle to the grave: activities of GATA‐3 throughout T‐cell development and differentiation , 2010, Immunological reviews.

[15]  Peter W. Laird,et al.  Interplay between the Cancer Genome and Epigenome , 2013, Cell.

[16]  W. Reik,et al.  An intragenic methylated region in the imprinted Igf2 gene augments transcription , 2001, EMBO reports.

[17]  H. Tsuda,et al.  NKX2.2 is a Useful Immunohistochemical Marker for Ewing Sarcoma , 2012, The American journal of surgical pathology.

[18]  G. Felsenfeld,et al.  Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene , 2000, Nature.

[19]  T. Moore,et al.  Multiple imprinted sense and antisense transcripts, differential methylation and tandem repeats in a putative imprinting control region upstream of mouse Igf2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Pellegrini,et al.  Conservation and divergence of methylation patterning in plants and animals , 2010, Proceedings of the National Academy of Sciences.

[21]  K. Kaarniranta,et al.  Fibrillin-2, tenascin-C, matrilin-2, and matrilin-4 are strongly expressed in the epithelium of human granular and lattice type I corneal dystrophies , 2012, Molecular vision.

[22]  C. Bock.  Analysing and interpreting DNA methylation data , 2012, Nature Reviews Genetics.

[23]  A. Bittner,et al.  Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer , 2009, BMC Cancer.

[24]  S. Kohsaka,et al.  Promoter hypomethylation regulates CD133 expression in human gliomas , 2008, Cell Research.

[25]  N. Harpaz,et al.  Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. , 2007, Gastroenterology.

[26]  S. Landas,et al.  Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease , 2012, Inflammatory bowel diseases.

[27]  W. Reik,et al.  An upstream repressor element plays a role in Igf2 imprinting , 2001, The EMBO journal.

[28]  Wolf Reik,et al.  Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops , 2004, Nature Genetics.

[29]  Timothy E. Reddy,et al.  Dynamic DNA methylation across diverse human cell lines and tissues , 2013, Genome research.

[30]  H. Clevers.  Wnt breakers in colon cancer. , 2004, Cancer cell.

[31]  K. Hess,et al.  Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer. , 2011, JAMA.

[32]  J. Zhai,et al.  Conservation and divergence in eukaryotic DNA methylation , 2010, Proceedings of the National Academy of Sciences.

[33]  S. Baylin,et al.  Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. , 1999, Cancer research.

[34]  A. Bird.  DNA methylation patterns and epigenetic memory. , 2002, Genes & development.

[35]  J. Bell,et al.  A Genome-Wide Study of DNA Methylation Patterns and Gene Expression Levels in Multiple Human and Chimpanzee Tissues , 2011, PLoS genetics.

[36]  A. Feinberg,et al.  Genome-wide methylation analysis of human colon cancer reveals similar hypo- and hypermethylation at conserved tissue-specific CpG island shores , 2008, Nature Genetics.

[37]  A. Feinberg,et al.  DNA methyltransferase 1 and 3B activate BAG-1 expression via recruitment of CTCFL/BORIS and modulation of promoter histone methylation. , 2008, Cancer research.

[38]  Lawrence C. LaPointe,et al.  CAHM, a long non-coding RNA gene hypermethylated in colorectal neoplasia , 2014, Epigenetics.

[39]  S. Brady-Kalnay,et al.  Cancer cells cut homophilic cell adhesion molecules and run. , 2011, Cancer research.

[40]  Rolf Ohlsson,et al.  CTCF binding at the H19 imprinting control region mediates maternally inherited higher-order chromatin conformation to restrict enhancer access to Igf2. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Thomas Lengauer,et al.  Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues , 2012, Epigenetics.

[42]  T. Bestor,et al.  Eukaryotic cytosine methyltransferases. , 2005, Annual review of biochemistry.

[43]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[44]  Robin M. Murray,et al.  Epigenome-Wide Scans Identify Differentially Methylated Regions for Age and Age-Related Phenotypes in a Healthy Ageing Population , 2012, PLoS genetics.

[45]  D. Haussler,et al.  Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. , 2005, Genome research.

[46]  A. Iafrate,et al.  Expression of Oligodendroglial and Astrocytic Lineage Markers in Diffuse Gliomas: Use of YKL-40, ApoE, ASCL1, and NKX2-2 , 2006, Journal of neuropathology and experimental neurology.

[47]  James B. Mitchell,et al.  Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. , 2004, Cancer cell.

[48]  K. Mimori,et al.  FOXC2 is a Novel Prognostic Factor in Human Esophageal Squamous Cell Carcinoma , 2011, Annals of Surgical Oncology.

[49]  J. Rogers,et al.  DNA methylation profiling of human chromosomes 6, 20 and 22 , 2006, Nature Genetics.

[50]  Peter A. Jones,et al.  The Role of DNA Methylation in Mammalian Epigenetics , 2001, Science.

[51]  Rafael A. Irizarry,et al.  Genome-wide methylation analysis of human colon cancer reveals similar hypo- and hypermethylation at conserved tissue-specific CpG island shores , 2008, Nature Genetics.

[52]  Sven Laur,et al.  Robust rank aggregation for gene list integration and meta-analysis , 2012, Bioinform..

[53]  T. Mikkelsen,et al.  Genome-scale DNA methylation maps of pluripotent and differentiated cells , 2008, Nature.

[54]  V. Corces,et al.  Enhancer function: new insights into the regulation of tissue-specific gene expression , 2011, Nature Reviews Genetics.

[55]  A. Gnirke,et al.  Charting a dynamic DNA methylation landscape of the human genome , 2013, Nature.

[56]  Peter A. Jones.  Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.

[57]  J. Herman,et al.  5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.

[58]  Christian Schmidl,et al.  Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity. , 2009, Genome research.

[59]  H. Clevers,et al.  Linking Colorectal Cancer to Wnt Signaling , 2000, Cell.

[60]  Stephan Beck,et al.  Probe Lasso: A novel method to rope in differentially methylated regions with 450K DNA methylation data , 2015, Methods.

[61]  Andrew E. Teschendorff,et al.  ChAMP: 450k Chip Analysis Methylation Pipeline , 2014, Bioinform..

[62]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[63]  H. Putter,et al.  Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis , 2004, Laboratory Investigation.

[64]  Yoshihiro Yamanishi,et al.  Supervised enzyme network inference from the integration of genomic data and chemical information , 2005, ISMB.

[65]  Gangning Liang,et al.  Gene body methylation can alter gene expression and is a therapeutic target in cancer. , 2014, Cancer cell.

[66]  Wei Dong Chen,et al.  Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer , 2004, Nature Genetics.

[67]  Xia Li,et al.  Integrating epigenetic marks for identification of transcriptionally active miRNAs. , 2014, Genomics.

[68]  James A. Heward,et al.  Long non-coding RNAs in the regulation of the immune response , 2014, Trends in Immunology.

[69]  K. Robertson.  DNA methylation and human disease , 2005, Nature Reviews Genetics.